Strados Labs Awarded $990K to Develop Wearable Lung Sensor

Strados Labs has been awarded a $990,118 grant to advance the development of its RESP Smart Sensor Platform, a noninvasive wearable lung device to help in the early detection of chronic obstructive pulmonary disease (COPD) and other respiratory infectious conditions.

The funds are part of a second phase of a two-year Small Business Innovation Research grant from the National Science Foundation (NSF).

COPD is a chronic inflammatory disease of the lungs that causes several symptoms that make breathing difficult, such as persistent cough with mucus, wheezing, and shortness of breath.

These symptoms may be detected with a stethoscope, however, abnormal sounds may not occur during an examination, which may hamper COPD diagnosis. Also, physicians may not interpret and classify lung sounds in the same manner, further introducing a degree of variability to a diagnosis.

Strados created the RESP Smart Sensor Platform, an algorithm-based device that’s able to remotely detect changes in lung sounds and breathing patterns in real-time early in the disease course.

“It’s such an honor to receive this grant from such a highly regarded agency as the National Science Foundation,” Nick Delmonico, co-founder and CEO of Strados, said in a press release.

Read the full article here.